Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease

Rukhsana Shaikh-Zaidi; A. Lubetsky; A. Inbal; C. Dash

doi:10.1111/hae.12843

Pharmacokinetic profile of Optivate^® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease

Rukhsana Shaikh-Zaidi^*, A. Lubetsky, A. Inbal, C. Dash

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e64-e67
Journal	Haemophilia
Volume	22
Issue number	1
DOIs	https://doi.org/10.1111/hae.12843
State	Published - 1 Jan 2016

Access to Document

10.1111/hae.12843

Cite this

@article{a40327900cef4705a21da9727727f5d7,

title = "Pharmacokinetic profile of Optivate{\textregistered} (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease",

author = "Rukhsana Shaikh-Zaidi and A. Lubetsky and A. Inbal and C. Dash",

year = "2016",

month = jan,

day = "1",

doi = "10.1111/hae.12843",

language = "אנגלית",

volume = "22",

pages = "e64--e67",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease

AU - Shaikh-Zaidi, Rukhsana

AU - Lubetsky, A.

AU - Inbal, A.

AU - Dash, C.

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84958895862&partnerID=8YFLogxK

U2 - 10.1111/hae.12843

DO - 10.1111/hae.12843

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:84958895862

SN - 1351-8216

VL - 22

SP - e64-e67

JO - Haemophilia

JF - Haemophilia

IS - 1

ER -

Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease

Access to Document

Other files and links

Cite this

Pharmacokinetic profile of Optivate^® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease